Patent Assignment
Reel/Frame 044958/0377
Security Interest
Recorded: 2017-12-20
Pages: 149
Assignor
LEXICON PHARMACEUTICALS, INC.
Executed: 2017-12-04
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(503)
Modulators of G Protein-Coupled Receptor 88
PCT:
PCT/US2010/051572 ↗
Modulators of G Protein-Coupled Receptor 88
PCT:
PCT/US2010/051597 ↗
Modulators of G Protein-Coupled Receptor 88
PCT:
PCT/US2010/051614 ↗
Antibodies to Notum Pectinacetylesterase
PCT:
PCT/US2011/061785 ↗
MST1 Kinase Inhibitors and Methods of Their Use
PCT:
PCT/US2012/027376 ↗
Inhibitors of Adapter Associated Kinase 1, Compositions Comprising Them, and Methods of Their Use
PCT:
PCT/US2015/020696 ↗
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Application:
07/397,707 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Application:
07/748,342 →
Postive-Negative Selection Methods and Vectors
Patent:
5,464,764 →
Application:
08/014,083 →
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Patent:
5,487,992 →
Application:
08/084,741 →
Methods for the Genetic Modification of Endogenous Genes in Animal Cells Homologous Recombination
Patent:
5,614,396 →
Application:
08/200,011 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Application:
08/216,121 →
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Patent:
5,627,059 →
Application:
08/461,827 →
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Patent:
5,631,153 →
Application:
08/463,813 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Application:
08/563,138 →
Ku Deficient Cells and Non-Human Transgenic Animals
Patent:
5,955,644 →
Application:
08/695,866 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Application:
08/700,324 →
Xeroderma Pigmentosum Deficient Mouse
Patent:
5,948,952 →
Application:
08/708,958 →
MMRAD51-Deficient Cells and Transegenic Mice
Patent:
6,057,489 →
Application:
08/710,117 →
Indexed Library of Cells Containing Genomic Modifications and Methods of Making and Utilizing the Same
Patent:
6,136,566 →
Application:
08/726,867 →
Disruption of the Mammalian RAD51 Protein and Disruption of Proteins That Associate with Mammalian RAD51 for Hindering Cell Proliferation and/or Viability of Proliferating Cells
Patent:
6,037,125 →
Application:
08/758,280 →
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Patent:
6,204,061 →
Application:
08/781,559 →
Method for Chromosomal Rearrangement by Consecutive Gene Targeting of Two Recombination Substrates to the Deletion Endpoints
Patent:
6,077,667 →
Application:
08/883,616 →
Targeted Gene Discovery
Patent:
6,139,833 →
Application:
08/907,598 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Patent:
5,789,215 →
Application:
08/908,348 →
An Indexed Library of Cells Containing Genomic Modifications and Methods of Making and Utilizing the Same
Patent:
6,207,371 →
Application:
08/942,806 →
Disruption of the Mammalian RAD51 Protein and Disruption of Proteins That Associate with Mammalian RAD51 for Hindering Cell Proliferation
Patent:
6,057,104 →
Application:
08/964,614 →
Vectors for Gene Trapping and Gene Activation
Patent:
6,080,576 →
Application:
09/057,328 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Application:
09/116,298 →
Method of Constructing Vectors for Homologous Recombination Directed Mutagenesis
Patent:
6,924,146 →
Application:
09/171,642 →
Gene Targeting in Animal Cells Using Isogenic Dna Constructs
Patent:
6,653,113 →
Application:
09/253,818 →
Vectors for Gene Mutagenesis and Gene Discovery
Patent:
6,436,707 →
Application:
09/276,533 →
Construction of Normalized Cdna Libraries from Eucaryotic Cells
Patent:
6,218,123 →
Application:
09/371,257 →
Vectors for Gene Mutagenesis and Gene Discovery
Patent:
6,808,921 →
Application:
09/443,282 →
Novel Mammalian Cortexin-Like Proteins and Polynucleotides Encoding the Same
Patent:
6,579,715 →
Application:
09/484,906 →
Novel Human Uncoupling Proteins and Polynucleotides Encoding the Same
Patent:
6,403,784 →
Application:
09/501,558 →
Novel Lipoxygenase Proteins and Polynucleotides Encoding the Same
Patent:
6,582,957 →
Application:
09/547,435 →
Method Chromosomal Rearrangement by Consecutive Gene Targeting of Two Recombination Substrates to the Deletion Endpoints
Patent:
6,395,487 →
Application:
09/552,219 →
Method for Chromosomal Rearrangement by Consecutive Gene Targeting of Two Recombination Substrates to the Deletion Endpoints
Patent:
6,461,818 →
Application:
09/552,626 →
Nucleic Acids Encoding Human Transporter Proteins
Patent:
6,548,271 →
Application:
09/556,916 →
Novel human genes and proteins encoded thereby
Application:
09/579,114 →
Novel human genes and proteins encoded thereby
Application:
09/602,833 →
Novel mutated mammalian cells and animals
Application:
09/620,607 →
Indexed Library of Cells Containing Genomic Modifications and Methods of Making and Utilizing the Same
Patent:
6,855,545 →
Application:
09/639,453 →
Novel Human Endothelin Converting Enzyme-Like Proteins and Polynucleotides Encoding the Same
Patent:
6,524,840 →
Application:
09/667,373 →
Novel human protease inhibitor-like proteins and polynucleotides encoding the same
Application:
09/667,380 →
Novel Human Carboxypeptidases and Polynucleotides Encoding the Same
Patent:
6,441,153 →
Application:
09/675,305 →
Novel human galanin family proteins and polynucleotides encoding the same
Application:
09/689,911 →
Novel human proteins and Polynucleotides encoding the same
Application:
09/691,343 →
Novel Human Proteins and Polynucleotides Encoding the Same
Patent:
6,743,907 →
Application:
09/691,344 →
Novel Human Transporter Proteins and Polynucleotides Encoding the Same
Patent:
7,268,222 →
Application:
09/703,253 →
Novel Human Kinase Protein and Polynucleotides Encoding the Same
Patent:
6,720,173 →
Application:
09/707,121 →
Novel Human Atpase Proteins and Polynucleotides Encoding the Same
Patent:
6,462,186 →
Application:
09/710,092 →
Novel Human Proteases and Polynucleotides Encoding the Same
Patent:
6,441,154 →
Application:
09/710,099 →
Novel human Notch ligand proteins and polynucleotides encoding the same
Application:
09/714,882 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
09/714,883 →
Cells and Non-Human Organisms Containing Predetermined Genomic Modifications and Positive-Negative Selection Methods and Vectors for Making Same
Patent:
6,689,610 →
Application:
09/724,962 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
09/728,444 →
Publication:
US 2002/0161207
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
09/728,446 →
Publication:
US 2002/0081668
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Novel Human Transferase Proteins and Polynucleotides Encoding the Same
Novel human membrane proteins and polynucleotides encoding the same
Application:
09/735,712 →
Publication:
US 2002/0045743
Novel Human Kinase Protein and Polynucleotides Encoding the Same
Novel Human Gaba Receptor Proteins and Polynucleotides Encoding the Same
Polynucleotides Encoding Human Neurexin-Like Proteins
Application:
09/770,643 →
Publication:
US 2002/0077464
Novel human membrane proteins and polynucleotides encoding the same
Application:
09/771,961 →
Publication:
US 2002/0115837
Novel human membrane proteins and polynucleotides encoding the same
Application:
09/775,181 →
Publication:
US 2002/0038013
Novel Human Proteases and Polynucleotides Encoding the Same
Novel Human Thrombospondin Repeat Proteins and Polynucleotides Encoding the Same
Novel human regulatory protein and polynucleotides encoding the same
Application:
09/790,318 →
Publication:
US 2002/0038012
Novel Human Transferase Proteins and Polynucleotides Encoding the Same
Human Transporter Proteins and Polynucleotides Encoding the Same
Polynucleotides and Polypeptides Encoding Human Transporter Proteins
Application:
09/800,103 →
Publication:
US 2002/0082405
Novel Human G-Coupled Protein Receptor Kinases and Polynucleotides Encoding the Same
Novel human phospholipases and polynucleotides encoding the same
Application:
09/804,969 →
Publication:
US 2002/0081595
Human Secreted Proteins and Polynucleotides Encoding the Same
Human Ion Channel Proteins and Polynucleotides Encoding the Same
Application:
09/818,990 →
Novel Human Metalloprotease and Polynucleotides Encoding the Same
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Novel Human Semaphorin Homologs and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Patent:
6,541,252 →
Application:
09/854,856 →
Novel human proteins and polynucleotides encoding the same
Application:
09/863,823 →
Novel Human Mitochondrial Proteins and Polynucleotides Encoding the Same
Patent:
6,790,667 →
Application:
09/870,113 →
Novel Human Transporter Proteins and Polynucleotides Encoding the Same
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
09/880,687 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
09/880,711 →
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Patent:
6,511,840 →
Application:
09/883,134 →
Polynucleotides Encoding Human Gaba Receptors
Novel human secreted signal proteins and polynucleotides encoding the same
Application:
09/898,456 →
Polynucleotides encoding human secreted protein
Application:
09/899,514 →
Novel Human Thymosin Protein and Polynucleotides Encoding the Same
Patent:
6,887,685 →
Application:
09/915,178 →
Human Proteases and Polynucleotides Encoding Same
Patent:
6,448,388 →
Application:
09/930,872 →
Novel Human Gaba Transporter Protein and Polynucleotides Encoding the Same
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Novel human netrin-like proteins and polynucleotides encoding the same
Application:
09/952,474 →
Novel Human Hemicentin Proteins and Polynucleotides Encoding the Same
Patent:
6,867,291 →
Application:
09/953,096 →
Novel human protease inhibitor proteins and polynucleotides encoding the same
Application:
09/957,832 →
Publication:
US 2002/0115204
Polynucleotides Encoding Human Ion-Exchanger Proteins
Polynucleotide Encoding a Human Proteaseinhibitor
Application:
09/962,740 →
Publication:
US 2002/0107382
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
09/963,299 →
Novel Human Proteases and Polynocleotides Encoding the Same
Novel Human Membrane Proteins and Polynucleotides Encoding the Same
Patent:
6,777,232 →
Application:
09/969,532 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
09/971,121 →
Publication:
US 2002/0111477
Fluid Turbine Device
Human Serine/ Threonine Kinases and Polynucleotides Encoding Same
Novel human membrane protein and polynucleotides encoding the same
Application:
09/977,053 →
Novel Human Semaphorin Proteins and Polynucleotides Encoding the Same
Patent:
7,001,763 →
Application:
09/981,318 →
Novel Human Kinases and Polynucleotides Encoding the Same
Novel human Wnt-family protein and polynucleotides encoding the same
Application:
09/997,191 →
Novel Human Kinase and Polynucleotides Encoding the Same
Patent:
6,586,230 →
Application:
10/004,542 →
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Patent:
6,858,419 →
Application:
10/010,720 →
Novel Human Kinase and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Novel Human Protease Inhibitor and Polynucleotides Encoding the Same
Patent:
6,583,269 →
Application:
10/024,427 →
Novel Human Protocadherin Proteins and Polynucleotides Encoding the Same
Patent:
6,852,844 →
Application:
10/025,225 →
Novel Human Kinases and Polynucleotides Encoding the Same
Novel human secreted proteins and polynucleotides encoding the same
Application:
10/038,288 →
Publication:
US 2003/0166883
Novel Human 7TM Proteins and Polynucleotides Encoding the Same
Patent:
6,570,003 →
Application:
10/042,810 →
Novel Human Kinases and Polynucleotides Encoding the Same
Novel mutated mammalian cells and animals
Application:
10/060,066 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/060,069 →
Novel human transporter protein and polynucleotides encoding the same
Application:
10/060,974 →
Publication:
US 2002/0127674
Novel Human Dectin Proteins and Polynucleotides Encoding the Same
Novel human TEN-M4/cdz proteins and polynucleotides encoding the same
Application:
10/090,516 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/091,628 →
Publication:
US 2002/0164627
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
10/092,390 →
Publication:
US 2003/0013865
Novel Human Synaptotagmin and Polynucleotides Encoding the Same
Patent:
6,994,995 →
Application:
10/094,162 →
Novel human adhesin proteins and polynucleotides encoding the same
Application:
10/109,528 →
Novel Human Kinase and Polynucleotides Encoding the Same
Novel Human Synthetase and Polynucleotides Encoding the Same
Novel human nuclear transporters and polynucleotides encoding the same
Application:
10/132,089 →
Publication:
US 2003/0166893
Novel human Ig-domain proteins and polynucleotides encoding the same
Application:
10/139,136 →
Novel human semaphorin receptors and polynucleotides encoding the same
Application:
10/141,260 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
10/141,670 →
Novel Human Hydroxylases and Polynucleotides Encoding the Same
human EGF-family proteins and polynucleotides encoding the same
Application:
10/154,675 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/155,891 →
Publication:
US 2002/0193585
Vectors for Gene Mutagenesis and Gene Discovery
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/162,121 →
Human Uncoupling Proteins and Polynucleotides Encoding the Same
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/173,123 →
Publication:
US 2003/0027301
Novel human ig-domain proteins and polynucleotides encoding the same
Application:
10/180,477 →
Novel human kielin-like proteins and polynucleotides encoding the same
Application:
10/189,971 →
Publication:
US 2003/0028907
Novel Human Kinases and Polynucleotides Encoding the Same
Patent:
6,797,510 →
Application:
10/196,927 →
Novel Human Carboxypeptidases and Polynucleotides Encoding the Same
Novel Human Proteases and Polynucleotides Encoding the Same
Novel mutated mammalian cells and animals
Application:
10/202,489 →
Novel Human Proteases and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Novel Human G-Coupled Protein Receptor Kinases and Polynucleotides Encoding the Same
Novel Human Proteases and Polynucleotides Encoding the Same
Novel human collagen proteins and polynucleotides encoding the same
Application:
10/219,449 →
Publication:
US 2003/0077820
Novel human CUB-domain proteins and polynucleotides encoding the same
Application:
10/225,565 →
Novel human IG-domain protein and polynucleotides encoding the same
Application:
10/225,566 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/226,635 →
Novel Human Atpase Proteins and Polynucleotides Encoding the Same
Novel Human Kielin-Like Proteins and Polynucleotides Encoding the Same
Patent:
6,790,660 →
Application:
10/246,658 →
Human Ldl Receptor Encoding Polynucleotides
Novel Human Endothelin Converting Enzyme-Like Proteins and Polynucleotides Encoding the Same
Patent:
6,835,564 →
Application:
10/305,413 →
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Patent:
6,902,923 →
Application:
10/306,879 →
Novel human proteins and polynucleotides encoding the same
Application:
10/309,422 →
Publication:
US 2003/0139587
Novel human genes and proteins encoded thereby
Application:
10/322,836 →
Publication:
US 2006/0090212
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/345,884 →
Publication:
US 2003/0220491
Novel Human Transferase Proteins and Polynucleotides Encoding the Same
Novel human transporter proteins
Application:
10/368,687 →
Publication:
US 2003/0162713
Novel Human Kinases and Polynucleotides Encoding the Same
Novel Human Proteases and Polynucleotides Encoding the Same
Novel Human Protease Inhibitor and Polynucleotides Encoding the Same
Novel Human Kinase and Polynucleotides Encoding the Same
Novel Lipoxygenase Proteins and Polynucleotides Encoding the Same
Novel Human Kinase and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Novel human GABA receptor proteins and polynucleotides encoding the same
Application:
10/436,356 →
Publication:
US 2003/0229217
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Novel Human Kinase Proteins and Polynucleotides Encoding the Same
Novel human genes and proteins encoded thereby
Application:
10/681,744 →
Publication:
US 2005/0053953
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/702,075 →
Publication:
US 2004/0168209
Gene targeting in animal cells using isogenic DNA constructs
Application:
10/722,661 →
Publication:
US 2004/0107452
Novel human transferase proteins and polynucleotides encoding the same
Application:
10/730,882 →
Publication:
US 2004/0214202
Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
Application:
10/746,207 →
Publication:
US 2005/0149998
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/761,033 →
Publication:
US 2004/0138442
Novel Human Proteases and Polynucleotides Encoding the Same
Novel human membrane proteins and polynucleotides encoding the same
Application:
10/798,721 →
Publication:
US 2004/0248166
Novel Human Kinases and Polynucleotides Encoding the Same
Novel human proteins and polynucleotides encoding the same
Application:
10/813,588 →
Publication:
US 2005/0053969
Novel Human Semaphorin Homologs and Polynucleotides Encoding the Same
Novel Human Kielin-Like Proteins and Polynucleotides Encoding the Same
Novel human mitochondrial proteins and polynucleotides encoding the same
Application:
10/843,132 →
Publication:
US 2004/0204580
Novel Human Kinase and Polynucleotides Encoding the Same
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/843,704 →
Novel mutated mammalian cells and animals
Application:
10/846,839 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
10/859,018 →
Publication:
US 2005/0069919
Novel human phospholipases and polynucleotides encoding the same
Application:
10/861,920 →
Publication:
US 2005/0089886
Novel human membrane proteins and polynucleotides encoding the same
Application:
10/870,450 →
Publication:
US 2005/0164221
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/875,104 →
Human Ion-Exchanger Proteins
Novel human adhesin proteins and polynucleotides encoding the same
Application:
10/895,162 →
Novel human protease inhibitor-like proteins and polynucleotides encoding the same
Application:
10/901,801 →
Publication:
US 2005/0089892
Novel human protease inhibitor proteins and polynucleotides encoding the same
Application:
10/901,803 →
Publication:
US 2005/0059816
Novel human protocadherin proteins and polynucleotides encoding the same
Application:
10/917,242 →
Publication:
US 2005/0079522
Vectors for Making Genomic Modifications
Novel human TEN-M4/cdz proteins and polynucleotides encoding the same
Application:
10/919,053 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/924,751 →
Publication:
US 2005/0054049
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
10/935,709 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
10/941,305 →
Publication:
US 2005/0089965
Novel human membrane proteins and polynucleotides encoding the same
Application:
10/942,745 →
Publication:
US 2005/0124802
Methods and compositions for defining gene function
Application:
10/954,645 →
Publication:
US 2005/0118710
Novel human collagen proteins and polynucleotides encoding the same
Application:
10/958,858 →
Publication:
US 2005/0118626
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/960,789 →
Publication:
US 2005/0142588
Novel human CUB-domain proteins and polynucleotides encoding the same
Application:
10/962,211 →
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
10/972,983 →
Publication:
US 2005/0136456
Novel human netrin-like proteins and polynucleotides encoding the same
Application:
10/972,984 →
Novel human proteins and polynucleotides encoding the same
Application:
10/980,986 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
10/994,758 →
Publication:
US 2005/0164251
Novel human proteins and polynucleotides encoding the same
Application:
10/999,215 →
Publication:
US 2005/0170384
Novel human neurexin-like proteins and polynucleotides encoding the same
Application:
10/999,233 →
Publication:
US 2005/0096462
Novel human membrane protein and polynucleotides encoding the same
Application:
11/011,961 →
Novel human protease inhibitor proteins and polynucleotides encoding the same
Application:
11/012,588 →
Publication:
US 2005/0227343
Novel mutated mammalian cells and animals
Application:
11/021,492 →
Publication:
US 2006/0031947
Novel Human Kielin-Like Proteins and Polynucleotides Encoding the Same
Application:
11/022,296 →
Novel human notch ligand proteins and polynucleotides encoding the same
Application:
11/023,060 →
Publication:
US 2005/0170389
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Novel human transporter proteins and polynucleotides encoding the same
Application:
11/027,027 →
Publication:
US 2005/0181397
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Novel human secreted signal proteins and polynucleotides encoding the same
Application:
11/039,362 →
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
11/039,397 →
Novel human hemicentin proteins and polynucleotides encoding the same
Application:
11/049,637 →
Publication:
US 2005/0164277
Novel human thymosin protein and polynucleotides encoding the same
Application:
11/092,125 →
Publication:
US 2005/0221463
Novel Thiazoles and Methods of Their Use
Novel Thiazolopyrazoles and Methods of Their Use
Novel human nuclear transporters and polynucleotides encoding the same
Application:
11/135,604 →
Publication:
US 2005/0277767
Novel human kielin-like proteins and polynucleotides encoding the same
Application:
11/149,003 →
Publication:
US 2006/0014277
Novel human Ig-domain protein and polynucleotides encoding the same
Application:
11/177,675 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
11/179,018 →
Publication:
US 2006/0020125
Novel human GABA receptor proteins and polynucleotides encoding the same
Application:
11/188,353 →
Publication:
US 2006/0025581
Novel human IG-domain proteins and polynucleotides encoding the same
Application:
11/194,496 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
11/195,579 →
Novel human uncoupling proteins and polynucleotides encoding the same
Application:
11/196,524 →
Publication:
US 2006/0293512
Novel human synaptotagmin and polynucleotides encoding the same
Application:
11/230,321 →
Publication:
US 2006/0068485
Novel human membrane proteins and polynucleotides encoding the same
Application:
11/244,415 →
Publication:
US 2007/0298489
Novel human Ig-domain proteins and polynucleotides encoding the same
Application:
11/260,505 →
Novel human Wnt-family protein and polynucleotides encoding the same
Application:
11/260,694 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
11/285,738 →
Publication:
US 2006/0122380
Genetically engineered and phenotyped mice and stem cell clones for producing the same
Application:
11/318,121 →
Monoclonal Antibodies Against ANGPTL4
Genetically engineered and phenotyped mice and stem cell clones for producing the same
Application:
11/334,806 →
Knockout Animals Manifesting Hyperlipidemia
Patent:
7,402,730 →
Application:
11/347,838 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
11/354,210 →
Publication:
US 2008/0044896
4-Piperidin-1-Yl-7H-Pyrrolo[2,3-D]Pyrimidine Compounds
Novel human membrane proteins and polynucleotides encoding the same
Application:
11/356,592 →
Publication:
US 2008/0102520
Genetically engineered and phenotyped mice and stem cell clones for producing the same
Application:
11/400,067 →
Multicyclic compounds and methods of their use
Application:
11/433,057 →
Publication:
US 2006/0258672
Methods and compositions for improving cognition
Application:
11/433,626 →
Publication:
US 2006/0258691
Methods and compositions for defining gene function
Application:
11/441,837 →
Publication:
US 2006/0277612
Genetically engineered and phenotyped mice and stem cell clones for producing the same
Application:
11/488,469 →
Aryl Pyridines and Methods of Their Use
Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
Application:
11/508,116 →
Publication:
US 2007/0049608
Variants of FAM3C
Patent:
7,312,079 →
Application:
11/543,007 →
Novel lipoxygenase proteins and polynucleotides encoding the same
Application:
11/601,600 →
Publication:
US 2007/0136832
Antibodies to Novel Lipoxygenase Proteins
Application:
11/601,607 →
Publication:
US 2008/0125578
Multicyclic Amino Acid Derivatives and Methods of Their Use
Process for the Preparation of Substituted Phenylalanines
Imidazole-Based Compounds, Compositions Comprising Them and Methods of Their Use
Solid Forms of (3'-Chlorobiphenyl-4-Yl)(1-(Pyrimidin-2-Yl)Piperidin-4-Yl)Methanone and Methods of Their Use
Application:
11/832,728 →
Publication:
US 2008/0076788
Synthesis of Piperazines, Piperidines and Related Compounds
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Process for Preparing 5-Alkyl-7H-Pyrrolo[2,3-D] Pyrimindine-2-Ols
Amine-linked Multicyclic Compounds and Methods of Their Use
Application:
11/935,011 →
Publication:
US 2008/0139598
(S)-Phenyl(Heterocycle)Methanol-Based Compounds, Compositions Comprising Them and Methods of Their Use
Application:
11/935,040 →
Publication:
US 2008/0146600
(R)-Phenyl(Heterocycle)Methanol-Based Compounds, Compositions Comprising Them and Methods of Their Use
Application:
11/935,051 →
Publication:
US 2008/0146596
Methods of Treating Cognitive Impairment and Dementia
Application:
11/935,081 →
Publication:
US 2008/0153811
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds and Methods of Their Use
4-Amino-1H-Pyrimidin-2-One Based Compounds, Compositions Comprising Them and Methods of Their Use
O-Linked Pyrimidin-4-Amine-Based Compounds, Compositions Comprising Them, and Methods of Their Use to Treat Cancer
Genetically engineered and phenotyped mice and stem cell clones for producing the same
Application:
11/978,234 →
Publication:
US 2008/0189799
Monoclonal Antibodies Against ANGPTL3
Methods and compositions for the treatment of pain, inflammation and cancer
Application:
12/015,714 →
Publication:
US 2008/0194557
Methods and compositions for the treatment of body composition disorders
Application:
12/015,728 →
Publication:
US 2008/0200458
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Piperdine-Based Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same
Application:
12/057,851 →
Publication:
US 2009/0113564
Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same
Application:
12/099,459 →
Publication:
US 2009/0193532
Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same
Application:
12/099,465 →
Publication:
US 2009/0077680
Methods of Preparing Imidazole-Based Compounds
Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
Application:
12/101,445 →
Publication:
US 2008/0275099
Methods of Treating Serotonin-Mediated Diseases and Disorders
Application:
12/144,821 →
Publication:
US 2009/0005381
Particulate (3'-Chlorobiphenyl-4-Yl)(1-(Pyrimidin-2-Yl)Piperidin-4-Yl)Methanone and Methods of Its Use
Application:
12/147,589 →
Publication:
US 2009/0005407
Methods and Compositions for Treating Pulmonary Hypertension and Related Diseases and Disorders
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Methods of Affecting Gastrointestinal Transit and Gastric Emptying, and Compounds Useful Therein
Application:
12/174,741 →
Publication:
US 2009/0029993
Substituted Pyrrolo[2,3-D]Pyrimidines as Lim Kinase 2 Inhibitors
Methods of Preparing 4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds
Application:
12/196,341 →
Publication:
US 2009/0062540
Compositions and Methods for Treating Immunological and Inflammatory Diseases and Disorders
Solid Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)-Pyrimidin-4-Yl)Phenyl)Propanoate and Methods of Their Use
Solid Forms of (S)-2-Amino-3-(4-(2-Amino-6-((R)-2,2,2-Trifluoro-1-(3'-Methoxybiphenyl-4-Yl)Ethoxy)Pyrimidin-4-Yl)Phenyl)Propanoic Acid and Methods of Their Use
Application:
12/246,735 →
Publication:
US 2009/0099206
Process for the Preparation of Substituted Phenylalanines
(S)-(3'_Chlorobiphenyl-4-Yl)(1-(Pyrimidin-2-Yl) Piperidin-4-Yl) Methanol and Compostitions Comprising the Same
Application:
12/409,640 →
Publication:
US 2009/0181992
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
(R)-Phenyl(Heterocycle)Methanol-Based Compounds, Compositions Comprising Them and Methods of Their Use
Application:
12/468,176 →
Publication:
US 2009/0286820
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds and Methods of Their Use
Methods of Treating Schizophrenia
Application:
12/484,337 →
Publication:
US 2009/0306100
Solid Forms of (1R,2S,3R)-1-(2-(Isoxazol-3-Yl)-1H-Imidazol-4-Yl)Butane-1,2,3,4-Tetraol and Methods of Their Use
Methods of Preparing Imidazole-Based Bicyclic Compounds
Solid Forms of (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Methylthio)Tetrahydro-2H-Pyran-3,4,5-Triol and Methods of Their Use
(E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone Oxime Dihydrate and Methods of Its Use
Combinations Comprising Bicyclic S1P Lyase Inhibitors
Application:
12/544,504 →
Publication:
US 2010/0048649
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Methods of Treating Rheumatoid Arthritis
Monoclonal Antibodies Against ANGPTL4
Multicyclic Compounds and Methods of Their Use
1-Phenyl-1H-Pyrazole-Based Compounds
Multicyclic Amino Acid Derivatives and Methods of Their Use
Methods of Affecting Gastrointestinal Transit and Gastric Emptying, and Compounds Useful Therein
Application:
12/754,284 →
Publication:
US 2010/0317664
Methods of Using 4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds
Sulfanyl-Tetrahydropyran-Based Compounds and Methods of Their Use
Methods of Preparing Imidazole-Based Compounds
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Methods of Treating Autoimmune and Inflammatory Diseases and Disorders
Application:
12/903,657 →
Publication:
US 2011/0082178
Methods of Treating Ulcerative Colitis
Application:
12/911,011 →
Publication:
US 2011/0263601
Methods of Preparing 1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone
Application:
12/911,172 →
Publication:
US 2011/0098482
Process for the Preparation of Substituted Phenylalanines
Application:
12/948,901 →
Publication:
US 2011/0124865
Methods of Treating Pulmonary Hypertension
Compounds Useful in the Preparation of Tryptophan Hydrroxylase Inhibitors
Monoclonal Antibodies Against ANGPTL3
Methods of Preparing 4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds
4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Solid Forms of 3-(4-(Aminomethyl)-1-(5-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Piperidine-4-Carboxamido)Phenyl Dimethylcarbamate
Solid Forms of (S)-2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)Pyrimidin-4-Yl)Phenyl)Propanoic Acid
Tryptophan Hydroxylase Inhibitors
Monoclonal Antibodies Against ANGPTL4
Methods of Treating Ulcerative Colitis
MST1 Kinase Inhibitors and Methods of Their Use
Solid Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)-Pyrimidin-4-Yl)Phenyl)Propanoate and Methods of Their Use
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
Application:
13/505,895 →
Publication:
US 2012/0316171
Methods of Treating Diabetes
Methods of Preparing 1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone
Application:
13/597,509 →
Publication:
US 2013/0109865
Imidazo[1,2-B]Pyridazine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Pyrazolo[1,5-A]Pyrimidine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Methods for Treating Pulmonary Hypertension
Application:
13/845,533 →
Publication:
US 2013/0274261
MST1 Kinase Inhibitors and Methods of Their Use
Application:
13/886,351 →
Publication:
US 2014/0051681
Sodium Glucose Co-Transporter Inhibitors and Methods of Their Use
Inhibitors of Sodium Glucose Cotransporter 1
4H-Thieno[3,2-C]Chromene-Based Inhibitors of Notum Pectinacetylesterase and Methods of Their Use
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Inhibitors of Adapter Associated Kinase 1, Compositions Comprising Them, and Methods of Their Use
Inhibitors of Sodium Glucose Cotransporter 1
Sodium Glucose Co-Transporter Inhibitors and Methods of Their Use
Application:
15/155,780 →
Publication:
US 2017/0087172
Novel Mammalian Genes and the Cortexin-Like Proteins Encoded Thereby
Application:
60/116,310 →
Novel Human Uncoupling Protein and Polynucleotides Encoding the Same
Application:
60/119,228 →
Novel Lipoxygenase-Like Genes and Proteins
Application:
60/128,817 →
Novel Human Transporter Protein
Application:
60/130,552 →
Novel Human Genes and Proteins Encoded Thereby
Application:
60/137,896 →
Novel Human Genes and Proteins Encoded Thereby
Application:
60/140,627 →
Novel Lipoxygenase Proteins and Polynucleotides Encoding the Same
Application:
60/150,454 →
Novel Human Proteins and Polynucleotides Encoding the Same
Application:
60/150,511 →
Novel Human Calcium Dependent Proteases and Polynucleotides Encoding the Same
Application:
60/152,057 →
Novel Human Protease Inhibitor-Like Proteins and Polynucleotides Encoding the Same
Application:
60/156,101 →
Novel Human Uncoupling Protein and Polynucleotides Encoding the Same
Application:
60/158,458 →
Novel Human Galanin Family Protein and Polynucleotide Encoding the Same
Application:
60/158,848 →
Novel Human Protein and Polynucleotides Encoding the Same
Application:
60/160,285 →
Novel Human Cub Domain Proteins and Polynucleotides Encoding the Same
Application:
60/163,018 →
Novel Human Membrane Proteins and Polynucleotides Encoding the Same
Application:
60/165,263 →
Novel Human Notch Ligand Proteins and Polynucleotides Encoding the Same
Application:
60/165,959 →
Novel Human Secreted Proteins and Polynucleotides Encoding the Same
Application:
60/166,429 →
Novel Murine Polynucleotide Sequences and Mutant Cells and Mutant Animals Defined Thereby
Application:
60/168,270 →
Novel Murine Polynucleotide Sequences and Mutant Cells and Mutant Animals Defined Thereby
Application:
60/168,360 →
Novel Human Transferase Protein and Polynucleotides Encoding the Same
Application:
60/170,408 →
Novel Human Membrane Proteins and Polynucleotides Encoding the Same
Application:
60/171,567 →
Novel Human Gaba Receptor Proteins and Polynucleotides Encoding the Same
Application:
60/176,692 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/178,557 →
Novel Human membrane proteins and polynucleotides encoding the same
Application:
60/179,001 →
Novel human transporter protein and polynucleotides encoding the same
Application:
60/179,973 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/180,414 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/182,422 →
Novel human proteins and polynucleotides encoding the same
Application:
60/183,583 →
Novel human regulatory protein and polynucleotides encoding the same
Application:
60/184,015 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/185,956 →
Novel human proteins and polynucleotides encoding the same
Application:
60/186,557 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/187,120 →
Novel human phospholipases and polynucleotides encoding the same
Application:
60/188,885 →
Novel human phospholipases and polynucleotides encoding the same
Application:
60/189,693 →
Novel human semaphorins and polynucleotides encoding the same
Application:
60/190,638 →
Novel human secreted protein and polynucleotides encoding the same
Application:
60/191,188 →
Novel Human Proteins and Polynucleotides Encoding the Same
Application:
60/192,218 →
Novel human secreted protein and polynucleotides encoding the same
Application:
60/193,639 →
Novel human metalloprotease and polynucleotides encoding the same
Application:
60/196,319 →
Novel human neurexin-like proteins and polynucleotides encoding the same
Application:
60/199,513 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/204,725 →
Novel human semaphorin homologs and polynucleotides encoding the same
Application:
60/205,274 →
Novel human proteins and polynucleotides encoding the same
Application:
60/206,414 →
Novel Human mitochondrial proteins and polynucleotides encoding the same
Application:
60/207,933 →
Novel human semaphorin homologs and polynucleotides encoding the same
Application:
60/208,893 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/210,045 →
Novel murine polynucleotide sequences mutant cells and mutant animals defined thereby
Application:
60/211,232 →
Novel human GABA receptors and polynucleotides encoding the same
Application:
60/214,083 →
Novel human secreted signaling protein and polynucleotides encoding the same
Application:
60/216,384 →
Novel human secreted protein and polynucleotides encoding the same
Application:
60/218,461 →
Novel human WNT protein homologs and polynucleotides encoding the same
Application:
60/219,890 →
Novel human thymosin protein and polynucleotides encoding the same
Application:
60/220,612 →
Novel Human GABA transporter protein and polynucleotides encoding the same
Application:
60/230,178 →
Novel human secreted signal proteins and polynucleotides encoding, the same
Application:
60/230,609 →
Novel human netrin-like proteins and ploynicleotides encoding the same
Application:
60/232,283 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/232,793 →
Novel human protease inhibitor proteins and polynucleotides encoding the same
Application:
60/234,100 →
Novel human protease inhibitor proteins and polynucleotides encoding same
Application:
60/235,744 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
60/237,273 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/237,280 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/239,629 →
Novel Human membrane protein and polynucleotides encoding the same
Application:
60/240,466 →
Novel human semaphorin-like proteins and polynucleotides encoding the same
Application:
60/241,194 →
Novel human protease inhibitor protein and polynucleotides encoding the same
Application:
60/241,195 →
Novel human secreted proteins and polynucleotides encoding the same
Application:
60/249,044 →
Novel human WNT-family protein and polynucleotides encoding the same
Application:
60/252,361 →
Novel human protocadherin proteins and polynucleotides encoding the same
Application:
60/257,257 →
Novel mutated mammalian cells and animals
Application:
60/265,574 →
Novel human transporter protein and polynucleotides encoding the same
Application:
60/266,136 →
Novel human dectin proteins and polynucleotides encoding the same
Application:
60/274,961 →
Novel human transporter protein and polynucleotides encoding the same
Application:
60/275,009 →
Novel human TEN-M4/cdz proteins and polynucleotides encoding the same
Application:
60/275,011 →
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
60/275,013 →
Novel human synaptotagmin and polynucleotides encoding the same
Application:
60/276,594 →
Novel human adhesin proteins and polynucleotides encoding the same
Application:
60/279,161 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/284,152 →
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
60/286,141 →
Novel human nuclear transporters and polynucleotides encoding the same
Application:
60/287,641 →
Novel human IG-family proteins and polynucleotides encoding the same
Application:
60/288,541 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/289,423 →
Novel human semaphorin receptors and polynucleotides encoding the same
Application:
60/289,424 →
Novel human membrane proteins and polynucleotides encoding the same
Application:
60/289,726 →
Novel human kinases and polynucleotides encoding the same
Application:
60/289,727 →
Novel human EGF-family proteins and polynucleotides encoding the same
Application:
60/293,709 →
Novel human transporter proteins and polynucleotides encoding the same
Application:
60/293,710 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
60/295,143 →
Novel human transporter proteins and polynucleotides encoding the came
Application:
60/298,241 →
Novel human Ig-domain proteins and polynucleotides encoding the same
Application:
60/301,606 →
Novel human kielin-like proteins and polynucleotides encoding the same
Application:
60/302,949 →
Novel mutated mammalian cells and animals
Application:
60/307,670 →
Novel human collagen proteins and polynucleotides encoding the same
Application:
60/312,300 →
Novel human Ig-domain protein and polynucleotides encoding the same
Application:
60/313,877 →
Novel human CUB-domain proteins and polynucleotides encoding the same
Application:
60/314,052 →
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
Application:
60/315,454 →
Novel human kielin-like proteins and polynucleotides encoding same
Application:
60/315,634 →
Novel human kielin-like proteins and polynucleotides encoding the same
Application:
60/323,068 →
Methods and compositions for defining gene function
Application:
60/507,437 →
Novel thiazolopyrazoles and methods of their use
Application:
60/557,699 →
Novel thiazoles and methods of their use
Application:
60/557,702 →
Agents and compositions for the treatment of hyperlipidemia
Application:
60/649,509 →
Substituted 4-piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
Application:
60/654,107 →
Substituted 4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds, compositions
Application:
60/675,254 →
Aprylpiperazines and related compounds and their use
Application:
60/680,501 →
Methods and compositions for defining gene function
Application:
60/684,927 →
Aryl pyridines and methods of their use
Application:
60/704,742 →
Pyrrolopyridine, pyrrolopyrimidine, and pyrazolopyridine compounds, compositions comprising them, and methods of their use
Application:
60/711,404 →
Variants of FAM3C
Application:
60/724,366 →
Process for the preparation of substituted phenylalanines
Application:
60/754,785 →
Multicyclic amino acid derivatives and methods of their use
Application:
60/754,955 →
Imidazole-based compounds, compositions comprising them and methods of their use
Application:
60/776,473 →
Methods for making antibodies in genetically engineered mice
Application:
60/781,620 →
Imidazole-based compounds, compositions comprising them and methods of their use
Application:
60/815,221 →
Solid forms of (3'-cholorobiphenyl-4-yl)(1-(pyrimidin-2-yl) piperidin-4-yl) methanone and methods of their use
Application:
60/835,677 →
Synthesis of piperazines, piperidines and related compounds
Application:
60/835,679 →
Methods for making antibodies in genetically engineered mice
Application:
60/839,408 →
Xylose and xyloside derivatives and methods of their use
Application:
60/848,156 →
Process for preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidine-2-ols
Application:
60/853,891 →
Amine-linked multicyclic compounds and methods of their use
Application:
60/857,389 →
(R)-Phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
Application:
60/857,453 →
(S)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
Application:
60/857,454 →
Methods of treating cognitive impairment and dementia
Application:
60/857,455 →
4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
Application:
60/874,596 →
4-Amino-1H-pyrimidin-2-one-based compounds, compositions comprising them and methods of their use
Application:
60/874,847 →
O-linked pyrimidin-4-amine-based compounds, compositions comprising them and methods of their use to treat cancer
Application:
60/874,882 →
Methods and compositions for identifying compounds useful in modulating neurological disorders in mammals
Application:
60/876,087 →
Methods and compositions for the treatment of body composition disorders
Application:
60/880,990 →
Methods and compositions for the treatment of pain, inflammation and cancer
Application:
60/881,090 →
Heterocyclic compounds, compositions comprising them and methods of their use
Application:
60/904,357 →
Xylose and xyloside derivatives and methods of their use
Application:
60/905,714 →
Methods of preparing imidazole-based compounds
Application:
60/923,029 →
Solid forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime
Application:
60/923,037 →
Methods of Treating Serotonin-Mediated Diseases and Disorders
Application:
60/946,246 →
Methods and Compositions for the treatment of gastrointestinal diseases and disorders
Application:
60/946,274 →
Particulate (3'-Chlorobiphenyl-4-Yl)(1-(Pyrimidin-2-Yl)Piperidin-4-Yl)Methanone and Methods of Its Use
Application:
60/946,765 →
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Application:
60/948,780 →
Methods And Compositions For Treating Pulmonary Hypertension And Related Diseases And Disorders
Application:
60/949,040 →
Methods Of Affecting Gastrointestinal Transit And Gastric Emptying, And Compounds Useful Therein
Application:
60/952,071 →
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Application:
60/952,122 →
Kinase Inhibitors, Compositions Comprising Them, and Methods of Their Use
Application:
60/954,698 →
Methods of Preparing 4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds
Application:
60/957,744 →
Compositions and Methods for Treating Immunological and Inflammatory Diseases and Disorders
Application:
60/970,416 →
Solid Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)Pyrimidin-4-Yl)Phenyl)Propanoate and Methods of Their Use
Application:
60/975,846 →
Solid Forms of (S)-2-Amino-3-(4-(2-Amino-6-((R)-2,2,2-Trifluoro-1-(3'-Methoxybiphenyl-4-Yl)Ethoxy)Pyrimidin-4-Yl)Phenyl)Propanoic Acid and Methods of Their Use
Application:
60/978,303 →
Combinations Comprising Bicyclic S1P Lyase Inhibitors
Application:
61/090,963 →
Bicyclic S1P Lyase Inhibitors For The Treatment Of Cerebral Malaria
Application:
61/109,987 →
Compositions and Methods For Treating Osteoporosis
Application:
61/118,521 →
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds For The Treatment Of Osteoporosis
Application:
61/118,764 →
Methods of Preparing 1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone
Application:
61/254,960 →
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
Application:
61/258,476 →
Process for the Preparation of Substituted Phenylalanines
Application:
61/262,834 →
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
Application:
61/303,395 →
MST1 Kinase Inhibitors and Methods of Their Use
Application:
61/449,171 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.